TaiMed Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	15,627	16,720	23,485	20,746	17,843	17,813
Market Cap Growth	-27.30%	-28.80%	13.20%	16.27%	0.17%	-16.02%
Enterprise Value	14,478	15,456	21,842	20,859	17,860	17,487
Last Close Price	57.20	61.20	86.00	80.83	69.69	69.59
Forward PE	-	-	-	282.76	-	-
PS Ratio	25.99	27.35	38.49	42.19	31.69	43.09
PB Ratio	4.12	4.33	5.84	8.09	6.57	6.06
P/TBV Ratio	4.62	4.89	6.74	10.69	8.96	8.40
P/FCF Ratio	201.19	99.24	-	-	-	-
P/OCF Ratio	155.69	87.47	-	-	-	-
EV/Sales Ratio	24.08	25.28	35.80	42.42	31.72	42.30
EV/FCF Ratio	186.39	91.74	-	-	-	-
Debt / Equity Ratio	0.13	0.13	0.13	0.29	0.28	0.19
Debt / FCF Ratio	6.28	2.93	-	-	-	-
Net Debt / Equity Ratio	-0.30	-0.33	-0.28	0.04	0.05	-0.13
Net Debt / EBITDA Ratio	106.63	27.42	10.81	-5.89	-2.92	1.16
Net Debt / FCF Ratio	-14.80	-7.57	2.91	-3.29	-0.20	1.77
Asset Turnover	0.13	0.13	0.14	0.12	0.13	0.08
Inventory Turnover	0.30	0.24	0.28	0.20	0.27	0.27
Quick Ratio	9.23	7.48	13.26	2.31	2.32	5.12
Current Ratio	16.83	13.11	25.18	5.96	6.56	10.37
Return on Equity (ROE)	-3.22%	-4.26%	-6.13%	-7.38%	-9.52%	-14.82%
Return on Assets (ROA)	-2.08%	-2.48%	-3.55%	-2.60%	-2.75%	-6.20%
Return on Capital Employed (ROCE)	-3.60%	-4.30%	-5.20%	-4.70%	-5.10%	-11.10%
Earnings Yield	-0.80%	-1.00%	-0.86%	-0.94%	-1.51%	-2.64%
FCF Yield	0.50%	1.01%	-1.65%	-0.15%	-3.41%	-1.24%
Buyback Yield / Dilution	-0.03%	-1.85%	-6.08%	-0.18%	-0.04%	-0.03%